11 completed, 3 not yet recruiting, 3 terminated, 1 recruiting. 7 Phase 3, 4 Phase 1, 3 Phase 2, 2 Not applicable, 1 Phase 4.
Follow Neurocysticercosis: new trials by email Literature Review of Neurocysticercosis trials Research Report on Neurocysticercosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oxfendazole in Mild Parenchymal Brain Cysticercosis Oxfendazole single dose, Oxfendazole three doses, albendazole plus praziquantel regime - Brain Cysticercosis | Phase 2 / Phase 3 | Not yet recruiting | Universidad Peruana Cayetano Heredia | 544 | 2026-12-01 | 2026-05-01 |
| The Impact of Medical TV Drama in Improving Literacy on Neurocysticercosis Medical TV Drama Episode (House M.D.) - Neurocysticercosis, Health Literacy | Not applicable | Not yet recruiting | Cephas Health Research Initiative Inc, Ibadan, Nigeria | 60 | 2025-12-15 | 2025-12-04 |
| Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis albendazole and praziquantel, Albendazole - Neurocysticercosis | Phase 4 | Not yet recruiting | R-Evolution Worldwide S.r.l. Impresa Sociale | 300 | 2024-06-01 | 2024-04-23 |
| Parenchymal and Extraparenchymal Neurocysticercosis-A Registry Based Study Neurocysticercosis, Tropical Disease | Unknown | All India Institute of Medical Sciences | 1000 | 2021-01-15 | 2021-01-13 | |
| Investigation of Environmental Factors Associated With Transmission of T. Solium in Endemic Villages of Zambia Neurocysticercosis, Taeniosis | Completed | Technical University of Munich | 2921 | 2019-06-01 | 2023-11-30 | |
| Treatment of Patients With Active Neurocysticercosis in Eastern Africa Neurocysticercosis | Completed | Technical University of Munich | 63 | 2019-04-01 | 2023-11-30 | |
| The Burden of (Neuro)Cysticercosis Among People Living With HIV in Rural Tanzania Diagnosis of (Neuro)cysticercosis - Neurocysticercosis, HIV/AIDS | Completed | Technical University of Munich | 2584 | 2018-04-01 | 2023-11-29 | |
| Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO) Albendazole and praziquantel, Albendazole and praziquantel placebo - Neurocysticercosis | Phase 3 | Terminated | Universidad Peruana Cayetano Heredia | 107 | 2016-11-14 | 2022-11-16 |
| Single Ascending Dose Safety Study of Oxfendazole oxfendazole, placebo - Tenia Solium Infection | Phase 1 | Withdrawn | Johns Hopkins Bloomberg School of Public Health | 2016-08-01 | 2016-08-30 | |
| Treatment of Peri-calcification Edema in Neurocysticercosis (NCC) Acetazolamide, Dexamethasone - Neurocysticercosis | Phase 2 / Phase 3 | Terminated | Universidad Peruana Cayetano Heredia | 4 | 2015-12-04 | 2025-04-01 |
| Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole Oxfendazole, Placebo - Neurocysticercosis | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 70 | 2014-11-17 | 2020-11-02 |
| People Presenting With Neurocysticercosis in North America Neurocysticercosis | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 11 | 2014-09-03 | 2018-04-05 | |
| Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT 7 days of albendazole 15 mg/kg/day, 28 days of albendazole 15 mg/kg/day - Neurocysticercosis | Phase 3 | Completed | All India Institute of Medical Sciences | 97 | 2014-03-01 | 2016-01-01 |
| Targeted Screening for Taenia Solium Tapeworms Niclosamide, Community education campaign - Taenia Solium Taeniasis | Not applicable | Completed | Oregon Health and Science University | 1811 | 2011-05-01 | 2014-10-24 |
| Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ) Praziquantel, Albendazole, ABZ Placebo - Neurocysticercosis, Epilepsy | Phase 2 / Phase 3 | Completed | Universidad Peruana Cayetano Heredia | 156 | 2010-01-01 | 2015-06-11 |
| PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB [F-18]FBR - Neurocysticercosis, Healthy | Phase 1 | Completed | National Institute of Mental Health (NIMH) | 24 | 2007-09-04 | 2018-07-05 |
| PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28 [C-11]PBR28 - Neurocysticercosis, Healthy | Phase 1 | Completed | National Institute of Mental Health (NIMH) | 18 | 2007-09-04 | 2019-12-12 |
| Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients Albendazole, Dexamethasone, Omeprazole - Neurocysticercosis | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 110 | 2006-04-01 | 2017-02-03 |
| A Pilot Study of Neurocysticercosis Treatment albendazole, placebo - Neurocysticercosis | Phase 3 | Completed | Columbia University | 178 | 2001-02-01 | 2010-02-08 |
| Natural History of Treated Neurocysticercosis and Long-Term Outcomes Cysticercosis, Neurocysticercosis | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 500 | 1985-10-07 | 2026-10-13 |
Taeniasis (9) · Epilepsy (5) · Cestode Infections (3) · Cysticercosis (3) · Seizures (3) · Hydrocephalus (2) · Neuroinflammatory Diseases (2) · Acquired Immunodeficiency Syndrome (1) · Meningitis, Aseptic (1) · Neglected Diseases (1)
Central Nervous System Diseases (20) · Central Nervous System Helminthiasis (20) · Central Nervous System Infections (20) · Central Nervous System Parasitic Infections (20) · Helminthiasis (20) · Infections (20) · Nervous System Diseases (20) · Parasitic Diseases (20) · Cestode Infections (17) · Cysticercosis (17) · Taeniasis (11) · Brain Diseases (7) · Pathological Conditions, Signs and Symptoms (6) · Neurologic Manifestations (3) · Pathologic Processes (3)
Albendazole (7) · Praziquantel (3) · oxfendazole (3) · Dexamethasone (2) · Acetazolamide (1) · Niclosamide (1) · Omeprazole (1)
National Institute of Allergy and Infectious Diseases (NIAID) (4) · Universidad Peruana Cayetano Heredia (4) · Technical University of Munich (3) · All India Institute of Medical Sciences (2) · National Institute of Mental Health (NIMH) (2) · Cephas Health Research Initiative Inc, Ibadan, Nigeria (1) · Columbia University (1) · Johns Hopkins Bloomberg School of Public Health (1) · Oregon Health and Science University (1) · R-Evolution Worldwide S.r.l. Impresa Sociale (1)
Peru (5) · United States (5) · Tanzania (2) · Ecuador (1) · India (1) · Zambia (1)
Hector H. Garcia, MD, PhD (2) · Masahiro Fujita, M.D. (2) · Ajay Garg, MD DM (1) · Armando Gonzalez, DVM PhD (1) · Arunmozhimaran Elavarasi, MD DM (1) · Bernard J Ngowi, MD, PhD (1) · Chummy S. Sikasunge, PhD (1) · E. Javier Pretell, MD (1) · Elise M O'Connell, M.D. (1) · Hector H Garcia, MD, PhD (1) · Hector H. Garcia Lescano, Ph.D (1) · Hector H. Garcia, MD (1) · Javier A. Bustos, MD (1) · Kabemba E. Mwape, Prof. (1) · Robert H Gilman, MD (1)
PMID 18495737, PMID 21332573, PMID 24999157, PMID 26984901, PMID 29749279, PMID 30745383, PMID 36961623, PMID 37983246, PMID 8615453, PMID 9364715, PMID 9840607
R01NS054805 (1), R21NS069275 (1)